Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
EMN · NYSE · United States · Plastic Materials, Synth Resins & Nonvulcan Elastomers
In shortEASTMAN CHEMICAL CO is profitable, generates cash and carries moderate debt, with revenue shrinking (−6.7% last year).
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | – | n/a |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 5.4% | 42/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 8.1% | 40/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.37× | 48/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.80× | 66/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | – | n/a |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 4.8% | 39/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.89× | 74/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 13.8% | 60/100 |
| Operating margin volatility | – | n/a |
Weight in the score: 20%
| Revenue growth, 3-year average | -6.1% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | -13.6% | 0/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 10,476 | 10,580 | 9,210 | 9,382 | 8,752 |
| Cost of revenue | 7,976 | 8,443 | 7,149 | 7,092 | 6,908 |
| Gross profit | 2,500 | 2,137 | 2,061 | 2,290 | 1,844 |
| Research & development | 254 | 264 | 239 | 250 | 255 |
| Selling, general & admin | 795 | 726 | 727 | 736 | 658 |
| Pre-tax income | 1,082 | 977 | 1,087 | 1,078 | 568 |
| Income tax | 215 | 181 | 191 | 170 | 93 |
| Net income | 857 | 793 | 894 | 905 | 474 |
| Diluted EPS | $6.25 | $6.35 | $7.49 | $7.67 | $4.10 |
| Diluted shares (millions) | 137 | 125 | 119 | 118 | 116 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: a required balance-sheet item is missing.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Jul 31, 2026